156 related articles for article (PubMed ID: 36103875)
21. Neurodevelopmental disorder associated with de novo SCN3A pathogenic variants: two new cases and review of the literature.
Inuzuka LM; Macedo-Souza LI; Della-Ripa B; Cabral KSS; Monteiro F; Kitajima JP; de Souza Godoy LF; de Souza Delgado D; Kok F; Garzon E
Brain Dev; 2020 Feb; 42(2):211-216. PubMed ID: 31677917
[TBL] [Abstract][Full Text] [Related]
22. A de novo missense variant in GABRA4 alters receptor function in an epileptic and neurodevelopmental phenotype.
Vogel FD; Krenn M; Westphal DS; Graf E; Wagner M; Leiz S; Koniuszewski F; Augé-Stock M; Kramer G; Scholze P; Ernst M
Epilepsia; 2022 Apr; 63(4):e35-e41. PubMed ID: 35152403
[TBL] [Abstract][Full Text] [Related]
23. De novo variants in AGO1 recapitulate a heterogeneous neurodevelopmental disorder phenotype.
Niu Y; Qian Q; Li J; Gong P; Jiao X; Mao X; Xiao B; Long L; Yang Z
Clin Genet; 2022 Apr; 101(4):459-465. PubMed ID: 35060114
[TBL] [Abstract][Full Text] [Related]
24. Clustered mutations in the GRIK2 kainate receptor subunit gene underlie diverse neurodevelopmental disorders.
Stolz JR; Foote KM; Veenstra-Knol HE; Pfundt R; Ten Broeke SW; de Leeuw N; Roht L; Pajusalu S; Part R; Rebane I; Õunap K; Stark Z; Kirk EP; Lawson JA; Lunke S; Christodoulou J; Louie RJ; Rogers RC; Davis JM; Innes AM; Wei XC; Keren B; Mignot C; Lebel RR; Sperber SM; Sakonju A; Dosa N; Barge-Schaapveld DQCM; Peeters-Scholte CMPCD; Ruivenkamp CAL; van Bon BW; Kennedy J; Low KJ; Ellard S; Pang L; Junewick JJ; Mark PR; Carvill GL; Swanson GT
Am J Hum Genet; 2021 Sep; 108(9):1692-1709. PubMed ID: 34375587
[TBL] [Abstract][Full Text] [Related]
25. A novel likely pathogenic heterozygous HECW2 missense variant in a family with variable expressivity of neurodevelopmental delay, hypotonia, and epileptiform EEG patterns.
Heide EC; Puk O; Biskup S; Krahn A; Rauf E; Kreilkamp BAK; Paulus W; Focke NK
Am J Med Genet A; 2021 Dec; 185(12):3838-3843. PubMed ID: 34327820
[TBL] [Abstract][Full Text] [Related]
26. De Novo Mutations Affecting the Catalytic Cα Subunit of PP2A, PPP2CA, Cause Syndromic Intellectual Disability Resembling Other PP2A-Related Neurodevelopmental Disorders.
Reynhout S; Jansen S; Haesen D; van Belle S; de Munnik SA; Bongers EMHF; Schieving JH; Marcelis C; Amiel J; Rio M; Mclaughlin H; Ladda R; Sell S; Kriek M; Peeters-Scholte CMPCD; Terhal PA; van Gassen KL; Verbeek N; Henry S; Scott Schwoerer J; Malik S; Revencu N; Ferreira CR; Macnamara E; Braakman HMH; Brimble E; Ruzhnikov MRZ; Wagner M; Harrer P; Wieczorek D; Kuechler A; Tziperman B; Barel O; de Vries BBA; Gordon CT; Janssens V; Vissers LELM
Am J Hum Genet; 2019 Jan; 104(1):139-156. PubMed ID: 30595372
[TBL] [Abstract][Full Text] [Related]
27. De novo variants in ATP2B1 lead to neurodevelopmental delay.
Rahimi MJ; Urban N; Wegler M; Sticht H; Schaefer M; Popp B; Gaunitz F; Morleo M; Nigro V; Maitz S; Mancini GMS; Ruivenkamp C; Suk EK; Bartolomaeus T; Merkenschlager A; Koboldt D; Bartholomew D; Stegmann APA; Sinnema M; Duynisveld I; Salvarinova R; Race S; de Vries BBA; Trimouille A; Naudion S; Marom D; Hamiel U; Henig N; Demurger F; Rahner N; Bartels E; Hamm JA; Putnam AM; Person R; Abou Jamra R; Oppermann H
Am J Hum Genet; 2022 May; 109(5):944-952. PubMed ID: 35358416
[TBL] [Abstract][Full Text] [Related]
28. De novo variants in EMC1 lead to neurodevelopmental delay and cerebellar degeneration and affect glial function in Drosophila.
Chung HL; Rump P; Lu D; Glassford MR; Mok JW; Fatih J; Basal A; Marcogliese PC; Kanca O; Rapp M; Fock JM; Kamsteeg EJ; Lupski JR; Larson A; Haninbal MC; Bellen H; Harel T
Hum Mol Genet; 2022 Sep; 31(19):3231-3244. PubMed ID: 35234901
[TBL] [Abstract][Full Text] [Related]
29. Variants in GNAI1 cause a syndrome associated with variable features including developmental delay, seizures, and hypotonia.
Muir AM; Gardner JF; van Jaarsveld RH; de Lange IM; van der Smagt JJ; Wilson GN; Dubbs H; Goldberg EM; Zitano L; Bupp C; Martinez J; Srour M; Accogli A; Alhakeem A; Meltzer M; Gropman A; Brewer C; Caswell RC; Montgomery T; McKenna C; McKee S; Powell C; Vasudevan PC; Brady AF; Joss S; Tysoe C; Noh G; Tarnopolsky M; Brady L; Zafar M; Schrier Vergano SA; Murray B; Sawyer L; Hainline BE; Sapp K; DeMarzo D; Huismann DJ; Wentzensen IM; Schnur RE; Monaghan KG; Juusola J; Rhodes L; Dobyns WB; Lecoquierre F; Goldenberg A; Polster T; Axer-Schaefer S; Platzer K; Klöckner C; Hoffman TL; MacArthur DG; O'Leary MC; VanNoy GE; England E; Varghese VC; Mefford HC
Genet Med; 2021 May; 23(5):881-887. PubMed ID: 33473207
[TBL] [Abstract][Full Text] [Related]
30. GABBR1 and SLC6A1, Two Genes Involved in Modulation of GABA Synaptic Transmission, Influence Risk for Alcoholism: Results from Three Ethnically Diverse Populations.
Enoch MA; Hodgkinson CA; Shen PH; Gorodetsky E; Marietta CA; Roy A; Goldman D
Alcohol Clin Exp Res; 2016 Jan; 40(1):93-101. PubMed ID: 26727527
[TBL] [Abstract][Full Text] [Related]
31. Further evidence for de novo variants in SYNCRIP as the cause of a neurodevelopmental disorder.
Semino F; Schröter J; Willemsen MH; Bast T; Biskup S; Beck-Woedl S; Brennenstuhl H; Schaaf CP; Kölker S; Hoffmann GF; Haack TB; Syrbe S
Hum Mutat; 2021 Sep; 42(9):1094-1100. PubMed ID: 34157790
[TBL] [Abstract][Full Text] [Related]
32. A novel splice site CUL3 variant in a patient with neurodevelopmental delay.
Vincent KM; Bourque DK
Brain Dev; 2023 Apr; 45(4):244-249. PubMed ID: 36710200
[TBL] [Abstract][Full Text] [Related]
33. A novel de novo variant of GABRA1 causes increased sensitivity for GABA in vitro.
Steudle F; Rehman S; Bampali K; Simeone X; Rona Z; Hauser E; Schmidt WM; Scholze P; Ernst M
Sci Rep; 2020 Feb; 10(1):2379. PubMed ID: 32047208
[TBL] [Abstract][Full Text] [Related]
34. GRIN2A-related disorders: genotype and functional consequence predict phenotype.
Strehlow V; Heyne HO; Vlaskamp DRM; Marwick KFM; Rudolf G; de Bellescize J; Biskup S; Brilstra EH; Brouwer OF; Callenbach PMC; Hentschel J; Hirsch E; Kind PC; Mignot C; Platzer K; Rump P; Skehel PA; Wyllie DJA; Hardingham GE; van Ravenswaaij-Arts CMA; Lesca G; Lemke JR;
Brain; 2019 Jan; 142(1):80-92. PubMed ID: 30544257
[TBL] [Abstract][Full Text] [Related]
35. A homozygous nonsense HECW2 variant is associated with neurodevelopmental delay and intellectual disability.
Krami AM; Bouzidi A; Charif M; Amalou G; Charoute H; Rouba H; Roky R; Lenaers G; Barakat A; Nahili H
Eur J Med Genet; 2022 Jun; 65(6):104515. PubMed ID: 35487419
[TBL] [Abstract][Full Text] [Related]
36. Haploinsufficiency underlies the neurodevelopmental consequences of SLC6A1 variants.
Silva DB; Trinidad M; Ljungdahl A; Revalde JL; Berguig GY; Wallace W; Patrick CS; Bomba L; Arkin M; Dong S; Estrada K; Hutchinson K; LeBowitz JH; Schlessinger A; Johannesen KM; Møller RS; Giacomini KM; Froelich S; Sanders SJ; Wuster A
Am J Hum Genet; 2024 Jun; 111(6):1222-1238. PubMed ID: 38781976
[TBL] [Abstract][Full Text] [Related]
37. Delineating SPTAN1 associated phenotypes: from isolated epilepsy to encephalopathy with progressive brain atrophy.
Syrbe S; Harms FL; Parrini E; Montomoli M; Mütze U; Helbig KL; Polster T; Albrecht B; Bernbeck U; van Binsbergen E; Biskup S; Burglen L; Denecke J; Heron B; Heyne HO; Hoffmann GF; Hornemann F; Matsushige T; Matsuura R; Kato M; Korenke GC; Kuechler A; Lämmer C; Merkenschlager A; Mignot C; Ruf S; Nakashima M; Saitsu H; Stamberger H; Pisano T; Tohyama J; Weckhuysen S; Werckx W; Wickert J; Mari F; Verbeek NE; Møller RS; Koeleman B; Matsumoto N; Dobyns WB; Battaglia D; Lemke JR; Kutsche K; Guerrini R
Brain; 2017 Sep; 140(9):2322-2336. PubMed ID: 29050398
[TBL] [Abstract][Full Text] [Related]
38. Expanding the genotype-phenotype correlation of de novo heterozygous missense variants in YWHAG as a cause of developmental and epileptic encephalopathy.
Kanani F; Titheradge H; Cooper N; Elmslie F; Lees MM; Juusola J; Pisani L; McKenna C; Mignot C; Valence S; Keren B; Lachlan K; ; Balasubramanian M
Am J Med Genet A; 2020 Apr; 182(4):713-720. PubMed ID: 31926053
[TBL] [Abstract][Full Text] [Related]
39. Variants in Mitochondrial ATP Synthase Cause Variable Neurologic Phenotypes.
Zech M; Kopajtich R; Steinbrücker K; Bris C; Gueguen N; Feichtinger RG; Achleitner MT; Duzkale N; Périvier M; Koch J; Engelhardt H; Freisinger P; Wagner M; Brunet T; Berutti R; Smirnov D; Navaratnarajah T; Rodenburg RJT; Pais LS; Austin-Tse C; O'Leary M; Boesch S; Jech R; Bakhtiari S; Jin SC; Wilbert F; Kruer MC; Wortmann SB; Eckenweiler M; Mayr JA; Distelmaier F; Steinfeld R; Winkelmann J; Prokisch H
Ann Neurol; 2022 Feb; 91(2):225-237. PubMed ID: 34954817
[TBL] [Abstract][Full Text] [Related]
40. SCN3A-Related Neurodevelopmental Disorder: A Spectrum of Epilepsy and Brain Malformation.
Zaman T; Helbig KL; Clatot J; Thompson CH; Kang SK; Stouffs K; Jansen AE; Verstraete L; Jacquinet A; Parrini E; Guerrini R; Fujiwara Y; Miyatake S; Ben-Zeev B; Bassan H; Reish O; Marom D; Hauser N; Vu TA; Ackermann S; Spencer CE; Lippa N; Srinivasan S; Charzewska A; Hoffman-Zacharska D; Fitzpatrick D; Harrison V; Vasudevan P; Joss S; Pilz DT; Fawcett KA; Helbig I; Matsumoto N; Kearney JA; Fry AE; Goldberg EM
Ann Neurol; 2020 Aug; 88(2):348-362. PubMed ID: 32515017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
